Featured Publications
Transurethral ventral inlay buccal mucosa graft urethroplasty: technique and intermediate outcomes
Sterling J, Daneshvar M, Nikolavsky D. Transurethral ventral inlay buccal mucosa graft urethroplasty: technique and intermediate outcomes. BJU International 2023, 132: 109-111. PMID: 36919248, DOI: 10.1111/bju.16007.Peer-Reviewed Original ResearchConceptsUrine flow rateVoid residualsExcellent intermediate-term outcomesInternational Prostate Symptom ScorePolydioxanone sutureDistal urethral stricturesMedian surgical timeIntermediate-term outcomesProstate Symptom ScoreSexual function scoresSingle-institution reviewBuccal mucosal graftPatient reported outcomesStep surgical techniqueMonths 95Urethroplasty successVentral urethrotomyVoid trialMean followPatient questionnaireProximal extentStricture recurrenceSymptom scoresTerm outcomesFossa navicularisEvaluation of the Effect of Tobacco Use on Buccal Mucosa Graft Histology
Policastro C, Sterling J, Porter B, Zaccarini DJ, Li G, Bratslavsky G, Nikolavsky D. Evaluation of the Effect of Tobacco Use on Buccal Mucosa Graft Histology. Urology 2022, 166: 264-270. PMID: 35469807, DOI: 10.1016/j.urology.2022.03.038.Peer-Reviewed Original ResearchConceptsTobacco useFormer usersBuccal mucosaBuccal mucosa graft urethroplastyCurrent usersGreater collagen densityOral mucosal tissuesCurrent tobacco usersPre-operative workupRegenerative mechanismsEpithelial stem cell markersBlinded histologic analysisStem cell markersGraft histologyControl patientsSmoking statusSingle pathologistStudy cohortGraft urethroplastyImmunohistochemical evaluationHistologic changesTobacco usersChi-square analysisIHC analysisSurgical casesLong-term outcomes from a multi-institutional experience with prefabricated composite gracilis-buccal mucosal flap for reconstruction of devastated urethras
Sterling J, Schardein J, Joshi PM, Kulkarni SB, Nikolavsky D. Long-term outcomes from a multi-institutional experience with prefabricated composite gracilis-buccal mucosal flap for reconstruction of devastated urethras. International Urology And Nephrology 2022, 54: 1047-1052. PMID: 35247151, DOI: 10.1007/s11255-022-03154-z.Peer-Reviewed Original ResearchConceptsPatient-reported outcome measuresGlobal response assessmentBuccal mucosal graftOutcome measuresMulti-institutional retrospective reviewSecondary outcome measuresPrimary outcome measureLong-term outcomesMulti-institutional experiencePost-operative surveyStage 2 repairStage 1Mean IPSSMean PVRStricture lengthCase seriesResultsFive patientsRetrospective reviewStricture recurrenceSuprapubic tubeSurgical optionsBulbar urethraMean ageMucosal graftPerineal urethrostomy
2022
Gender Affirmation Surgery, Transfeminine
Elyaguov J, Schardein J, Sterling J, Nikolavsky D. Gender Affirmation Surgery, Transfeminine. Urologic Clinics Of North America 2022, 49: 437-451. PMID: 35931435, DOI: 10.1016/j.ucl.2022.05.001.Peer-Reviewed Original ResearchThe Impact of Venous Thromboembolism on Mortality and Morbidity During Nephrectomy for Renal Mass
Patel HV, Sterling JA, Srivastava A, Ghodoussipour SB, Jang TL, Grandhi MS, August DA, Rahimi SA, Chung BI, Chang SL, Singer EA. The Impact of Venous Thromboembolism on Mortality and Morbidity During Nephrectomy for Renal Mass. Urology 2022, 168: 122-128. PMID: 35691439, DOI: 10.1016/j.urology.2022.05.033.Peer-Reviewed Original ResearchConceptsPreoperative venous thromboembolismTime of nephrectomyVenous thromboembolismRenal massesMajor complicationsRadical nephrectomyAssociation of VTEPresence of VTEConcurrent venous thromboembolismPremier Healthcare DatabaseDirect hospital costsMultivariable logistic regressionTypes of complicationsHigh rateICU admissionComplication rateSurgical resectionSurgical approachHospital costsNephrectomyPatientsHealthcare databasesComplicationsHigher overall costsLogistic regressionFactors Associated With Palliative Intervention Utilization for Metastatic Renal Cell Carcinoma
Patel HV, Kim S, Srivastava A, Shinder BM, Sterling J, Saraiya B, Mayer TM, Ghodoussipour S, Jang TL, Singer EA. Factors Associated With Palliative Intervention Utilization for Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer 2022, 20: 296-296.e9. PMID: 35105510, PMCID: PMC9149103, DOI: 10.1016/j.clgc.2022.01.001.Peer-Reviewed Original ResearchConceptsStage IV RCCMetastatic renal cell carcinomaNational Cancer DatabasePalliative interventionsRenal cell carcinomaMetastatic RCCClinical factorsCell carcinomaMultivariable logistic regression modelComprehensive cancer programsQuality of lifeLogistic regression modelsSarcomatoid histologyAdvanced malignanciesOverall cohortHigher education statusOncologic careInsurance statusCancer DatabaseCancer programsEarly initiationIntervention utilizationTreatment-specific mannerPatientsPI use
2020
Fourteen-Core Systematic Biopsy That Includes Two Anterior Cores in Men With PI-RADS Lesion ≥ 3 is Comparable With Magnetic Resonance Imaging-ultrasound Fusion Biopsy in Detecting Clinically Significant Prostate Cancer: A Single-institution Experience
Sterling J, Smith K, Farber N, Nagaya N, Jang TL, Singer EA, Sadimin E, Kim IY. Fourteen-Core Systematic Biopsy That Includes Two Anterior Cores in Men With PI-RADS Lesion ≥ 3 is Comparable With Magnetic Resonance Imaging-ultrasound Fusion Biopsy in Detecting Clinically Significant Prostate Cancer: A Single-institution Experience. Clinical Genitourinary Cancer 2020, 19: 275-279. PMID: 33153920, DOI: 10.1016/j.clgc.2020.09.006.Peer-Reviewed Original ResearchConceptsSystematic prostate biopsyProstate cancerProstate biopsyGleason scoreBiopsy resultsAnterior coreElevated prostate-specific antigenMagnetic resonance imaging-ultrasound fusion biopsyHigh-risk prostate cancerStandard template biopsyPercent of patientsSingle institution experienceC prostate cancerCsPCa detection ratesPositive biopsy resultsCancer detection rateSignificant prostate cancerProstate Imaging ReportingPI-RADS lesionsProstate-specific antigenTemplate prostate biopsyDetection rateMagnetic resonance imagingOverall detection rateSystematic biopsyUrologic oncology surgery during COVID-19: a rapid review of current triage guidance documents
Shinder BM, Patel HV, Sterling J, Tabakin AL, Kim IY, Jang TL, Singer EA. Urologic oncology surgery during COVID-19: a rapid review of current triage guidance documents. Urologic Oncology Seminars And Original Investigations 2020, 38: 609-614. PMID: 32507546, PMCID: PMC7260595, DOI: 10.1016/j.urolonc.2020.05.017.Peer-Reviewed Original ResearchFactors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of Care
Sterling J, Rivera-Núñez Z, Patel HV, Farber NJ, Kim S, Radadia KD, Modi PK, Goyal S, Parikh R, Weiss RE, Kim IY, Elsamra SE, Jang TL, Singer EA. Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of Care. Clinical Genitourinary Cancer 2020, 18: e643-e650. PMID: 32389458, PMCID: PMC7502425, DOI: 10.1016/j.clgc.2020.03.011.Peer-Reviewed Original ResearchConceptsNational Cancer Data BaseRenal cell carcinomaPartial nephrectomyClinical T1 renal cell carcinomaT1 renal cell carcinomaInvasive surgeryUtilization of MISRegionalization of careLower socioeconomic groupsT1b renal massesClinical T1aCT1a patientsCT1a tumorsCT1b patientsCT1b tumorsRCC surgeryTreatment disparitiesCell carcinomaPatient populationRenal massesInvasive treatmentPatientsAcademic centersLogistic regressionPrivate insurance
2016
Noninvasive Detection of Inflammatory Changes in White Adipose Tissue by Label-Free Raman Spectroscopy
Haka AS, Sue E, Zhang C, Bhardwaj P, Sterling J, Carpenter C, Leonard M, Manzoor M, Walker J, Aleman JO, Gareau D, Holt PR, Breslow JL, Zhou XK, Giri D, Morrow M, Iyengar N, Barman I, Hudis CA, Dannenberg AJ. Noninvasive Detection of Inflammatory Changes in White Adipose Tissue by Label-Free Raman Spectroscopy. Analytical Chemistry 2016, 88: 2140-2148. PMID: 26752499, PMCID: PMC4799653, DOI: 10.1021/acs.analchem.5b03696.Peer-Reviewed Original ResearchConceptsOverweight/obese individualsCurrent histopathological techniquesType 2 diabetesObesity-related diseasesWhite adipose tissueCardiometabolic complicationsInflammatory changesNormal weightObese individualsTissue inflammationOverweight individualsCardiovascular diseaseAdipose tissueHistopathological techniquesDisease riskTissue excisionDiseaseNoninvasive detectionLabel-free Raman spectroscopyObjective risk assessmentSubstantial numberHuman tissuesRiskTissueNoninvasive Raman spectroscopy